Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
Background Lymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and humans. LCMV has been engineered for the development of cancer immunotherapies, currently undergoing evaluation in phase I/II clinical trials. I...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2024-04-01
|
| coleção: | Journal for ImmunoTherapy of Cancer |
| Acesso em linha: | https://jitc.bmj.com/content/12/4/e008287.full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
